Ceribell (CBLL) Notes Payables (2023)
Ceribell's (CBLL) quarterly Notes Payables came in at $11.8 million in Q4 2023.
Ceribell (CBLL) Notes Payables (2023) Analysis & Trends
Ceribell (CBLL) has 1 years of Notes Payables data on file, last reported at $11.8 million in Q4 2023.
- Quarterly Notes Payables changed N/A year-over-year to $11.8 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $11.8 million (changed N/A YoY) and the FY2023 annual result came in at $11.8 million, changed N/A from the prior year.
- Notes Payables was little changed at $11.8 million in Q4 2023.
- In the past five years, Notes Payables ranged from a high of $11.8 million in Q4 2023 to a low of $11.8 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.61 Bn | 197.01 Bn | 7.27 Bn |
| 2 | Stryker | 127.33 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 119.23 Bn | 110.01 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.53 Bn | 73.99 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.84 Bn | 47.59 Bn | 1.35 Bn |
| 6 | Dexcom | 35.08 Bn | 33.14 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.86 Bn | 31.75 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.26 Bn | 22.94 Bn | 4.55 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn |
| 10 | Ceribell | 916.19 Mn | 786.93 Mn | 25.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 11.83 Mn |